Tibet Aim Pharm Inc
SZSE:002826
Tibet Aim Pharm Inc
Cash from Operating Activities
Tibet Aim Pharm Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tibet Aim Pharm Inc
SZSE:002826
|
Cash from Operating Activities
¥188.8m
|
CAGR 3-Years
21%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Cash from Operating Activities
¥4.2B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
2%
|
CAGR 10-Years
21%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash from Operating Activities
¥3.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash from Operating Activities
¥2.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
19%
|
CAGR 10-Years
22%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash from Operating Activities
¥8.7B
|
CAGR 3-Years
61%
|
CAGR 5-Years
26%
|
CAGR 10-Years
21%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash from Operating Activities
¥3.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
30%
|
CAGR 10-Years
12%
|
See Also
What is Tibet Aim Pharm Inc's Cash from Operating Activities?
Cash from Operating Activities
188.8m
CNY
Based on the financial report for Mar 31, 2024, Tibet Aim Pharm Inc's Cash from Operating Activities amounts to 188.8m CNY.
What is Tibet Aim Pharm Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
47%
Over the last year, the Cash from Operating Activities growth was 79%. The average annual Cash from Operating Activities growth rates for Tibet Aim Pharm Inc have been 21% over the past three years , 47% over the past five years .